COVID-19 updates: LA has highest daily death total since April

The labs shouldering much of the nation's PCR COVID-19 testing are getting slammed with demand again during omicron's surge, and now they're grappling with a new challenge: their workforces are getting hit by the virus they've been tasked with tracking.

The American Clinical Laboratory Association, the national trade association representing some of the leading clinical labs responsible for COVID diagnostics, is warning that their members' workforce is strained as more workers call out sick.

"Labs are now facing a wave of new issues brought on by a fast-spreading variant that has not spared the laboratory care work force," an ACLA spokesperson told ABC News.

COVID-19 infections have increased laboratory staff sick leave -- a "significant factor in determining overall capacity" at an industry-wide level, the spokesperson said.

"We have been pressured to get our capacity where we believe it can be because of the labor problems we see," Quest Diagnostics CEO Steve Rusckowski said Wednesday at the JPM Healthcare Conference. "Some of this is just getting the labor to do our work, but secondly, is because of callouts because of the virus have been considerable over the last two weeks."

-ABC News' Sasha Pezenik

Chicago teachers voted Wednesday to accept the deal made by the union and city to re start in-person classes.

The deal ended the five-day standoff after the union voted to switch to remote learning due to the omicron surge.

Union leaders made a tentative agreement on Monday and urged teachers to back the deal despite frustration that the district wouldn't grant demands for widespread coronavirus testing or commit to districtwide remote learning during a COVID-19 surge.

The final agreement will expand COVID-19 testing and create standards to switch schools to remote learning.

The deal also resulted in the purchase of KN95 masks for students and teachers and bigger incentives to attract substitute teachers. The city also agreed to give teachers unpaid leave related to the pandemic.

The U.S. Army released an update on the vaccine status of its members.

As of Jan. 11, 96% of members are fully vaccinated against COVID-19 and 97% have at least one dose, according to the Army.

All armed service members are mandated to be vaccinated against the coronavirus.

Around 18,000 members remain unvaccinated, the data showed.

The Army has chosen not to discharge unvaccinated soldiers but instead "flag" them so they’re not promoted and are not allowed to re-enlist. 

"To date, Army commanders have relieved a total of six active-duty leaders, including two battalion commanders, and issued 2,994 general officer written reprimands to soldiers for refusing the vaccination order," the Army said in a news release.

-ABC News' Luis Martinez

The U.S. government has purchased an additional 500,000 doses of Evusheld, AstraZeneca's monoclonal antibody drug, to be given before exposure to COVID-19, the company announced. This is on top of the 700,000 Evusheld doses already purchased.

White House officials previously said over 500,000 doses would be stockpiled in January and "significantly more" would be purchased by March."

Evusheld was authorized in December 2021 and is the first monoclonal therapy meant to be used in advance of an eligible person's exposure to COVID-19.

However, it's not meant for a wide group of people: this therapy is only authorized for immunocompromised people who may not have developed an optimal immune response to their vaccine. This therapy is also for people with a history of severe adverse reactions to a COVID-19 vaccine and thus aren't recommended to get vaccinated. 

Evusheld is not authorized as a way to treat COVID-19 after testing positive.

-ABC News' Sasha Pezenik